These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2964266)

  • 1. Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleens.
    Bear HD; Susskind BM; Close KA; Barrett SK
    Cancer Res; 1988 Mar; 48(6):1422-7. PubMed ID: 2964266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of I-region associated antigen (Ia)-bearing accessory cells in the generation of cytotoxic T cells in a subpopulation of thymocytes.
    Okuno K; Kikuchi Y; Tsuchida T; Hamaoka T; Igarashi T; Kato R; Takatsu K
    Jpn J Cancer Res; 1986 Jul; 77(7):711-21. PubMed ID: 3091558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of L3T4-positive T lymphocytes in the generation of anti-tumor immunity in the mouse.
    Yamamoto H; Takata M; Fujimoto S
    Jpn J Cancer Res; 1987 Feb; 78(2):176-84. PubMed ID: 2951356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of T cell differentiation factor in syngeneic lymphocyte macrophage culture for cytotoxic T lymphocyte generation.
    Ting CC; Hargrove ME; Loh NN
    J Immunol; 1986 Mar; 136(5):1726-33. PubMed ID: 2936809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T-suppressors from tumor-bearing mice inhibit antitumor cytotoxic T-lymphocytes in monoculture].
    Lupatov AIu; Brondz BD
    Biull Eksp Biol Med; 1992 Feb; 113(2):186-7. PubMed ID: 1535235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective thymic education of L3T4+ T helper cell function in graft-vs-host mice.
    Fukuzawa M; Via CS; Shearer GM
    J Immunol; 1988 Jul; 141(2):430-9. PubMed ID: 2968400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activation of L3T4+ helper T cells assisting the generation of anti-tumor Lyt-2+ cytotoxic T lymphocytes: requirement of Ia-positive antigen-presenting cells for processing and presentation of tumor antigens.
    Kosugi A; Yoshioka T; Suda T; Sano H; Takahama Y; Fujiwara H; Hamaoka T
    J Leukoc Biol; 1987 Dec; 42(6):632-41. PubMed ID: 2960766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of suppressor T cells by interleukin 2.
    Ting CC; Yang SS; Hargrove ME
    J Immunol; 1984 Jul; 133(1):261-6. PubMed ID: 6233372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the minimum requirements for in vitro "cure" of tumor cells by cytotoxic T lymphocytes.
    Miki S; Ksander B; Streilein JW
    Reg Immunol; 1992; 4(6):352-62. PubMed ID: 1297406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The syngeneic T-T lymphocyte reaction (STTLR). II. Induction of primary T anti-T cell cytotoxic responses in vitro in T cell cultures stimulated with syngeneic self-reactive T cells.
    Suzuki H; Quintáns J
    J Mol Cell Immunol; 1986; 2(6):345-57. PubMed ID: 3509919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic elimination of syngeneic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor-bearing mice.
    Lynch DH; Miller RE
    Eur J Immunol; 1991 Jun; 21(6):1403-10. PubMed ID: 1904359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self recognition of accessory cell Ia determinants is required for the in vitro generation of hapten-specific cytotoxic T lymphocyte responses.
    Kruisbeek AM; Andrysiak PM; Singer A
    J Immunol; 1983 Oct; 131(4):1650-5. PubMed ID: 6604748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
    Ciavarra RP
    Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation.
    Yang G; Hellström KE; Mizuno MT; Chen L
    J Immunol; 1995 Oct; 155(8):3897-903. PubMed ID: 7561096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.